No Benefits for Low-Dose Heparin Over Standard Heparin in FUTURA/OASIS-8

FUTURA (Fondaparinux Trial With Unfractionated Heparin During Revascularization in Acute Coronary Syndromes)/OASIS-8 is the first trial to compare low...

To continue reading, please log in to the right or request an invitation.